- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 20.12.2022
- Impfdatum
- 20.12.2022
- Beginn
- 20.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Confusional state
Hyperhidrosis
Loss of consciousness
Pallor
Posture abnormal
Symptomtext
at 4:15 pm: Pt was administered Menactra, Meningoccal B and HPV vaccines. Pt received two vaccines HPV and Menactra on left arm and during administration of the third vaccine, Truemba, She lowered her head and her eyes were open. She did not know where she was. Patient lost consciousness for approximately 45 seconds. Pt placed in supine position on exam table. She was pale and diaphoretic. Feet were elevated. Cool compress to forehead. Vitals: 109/65 HR 64 pulse ox 100%, Second BP 5 minutes later 98/45, HR 59, pulse ox 100%, Final BP 96/64 HR 64, pulse ox 100%. Pt awake and talking and oriented to place. Able to ambulate with steady gait. Mother present in room
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Anxiety, depression, dysmenorrhea
- Andere Medikamente
- Accutane, Tricyclen
- Allergien
- none
- Vorherige Impfungen
- Pt states that she had a reaction last year
- Staat
- SC
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 13.12.2022
- Impfdatum
- 13.12.2022
- Beginn
- 13.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Symptomtext
Client Fainted upon standing up
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- Birth Control Pills
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 27.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood creatinine normal
Blood magnesium normal
Dizziness
Electrocardiogram normal
Full blood count normal
Metabolic function test normal
Presyncope
Urine analysis normal
Symptomtext
Around 2PM, while at school, patient felt faint and had a near syncope. He was taken to the ED. He received IV fluids and evaluation. He went home within a few hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- normal CBC normal metabolic panel ( complete) including creatinine 1.3 Normal urine analysis normal magnesium normal EKG all obtained on 11/3/2022 around 5 pm.
- Aktuelle Erkrankungen
- had a fever 10/5/22, no clear etiology, resolved in 2 days
- Vorgeschichte
- chronic kidney disease, spina bifida, neurogenic bladder and bowels, tethered cord, radiculopathy right leg, depression, adhd, arnold chiari malformation,
- Andere Medikamente
- wellbutrin, ditropan, myrbetriq, dulcolax, vitamin D
- Allergien
- vancomycin and latex allergy avoids nsaids due to Chronic kidney disease
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 28.09.2022
- Impfdatum
- 28.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Laboratory test
Loss of consciousness
Symptomtext
Patient loss consciousness while standing at check-out about 15 minutes after receiving both vaccines. Patient also had labs collected via venipuncture after the vaccines where administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None, parent requested to take patient to emergency room
- Aktuelle Erkrankungen
- no known illness
- Vorgeschichte
- no known chronic conditions
- Andere Medikamente
- none or unknown
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 30.08.2022
- Impfdatum
- 30.08.2022
- Beginn
- 30.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Electrocardiogram
Loss of consciousness
Symptomtext
Patient passed out and lost consciousness approximately 5-10 minutes following vaccine administration
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- ECG was completed, following per provider's recommendations.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AS
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 23.08.2022
- Impfdatum
- 22.08.2022
- Beginn
- 22.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Symptomtext
Patient passed out from returning from bathroom after receiving shots. called for assistance and lost sight. Regained conciousness and was put on gerny, feet raised for 15 min until vitals returned to normal. no other adverse effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 22.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dystonia
Oxygen saturation
Pallor
Pyrexia
Tremor
Symptomtext
Dystonic reaction with pallor, full body shakes and fever to 102.7. Monitored in office for 1 hour. Shakes subsided after 50mg diphenhydramine in 15 minutes. Fever began to decrease after acetaminophen 1000 mg and left office with 101.6 temp.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- Monitoring of vital signs with pulse oximetry on date of event only.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 06.04.2023
- Impfdatum
- 05.04.2023
- Beginn
- 05.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain upper
Bradykinesia
Dizziness
Fatigue
Loss of personal independence in daily activities
Somnolence
Symptomtext
Patient's mother reports that by 7 PM last night that child was not "functioning" well and was moving slowly. He did not have any symptoms of anaphalaxis such as swelling, difficulty breathing, hives and he did not report any fever or pain at injection site. Mother did speak to child's physician who encouraged her to call health department. I advised that if child is still feeling sleepy and having stomach pain that she needs to seek medical care. Child currently at high school and texting mom that he feels like he is going to pass out and feels tired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- unknown
- Allergien
- NKMA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 06.03.2023
- Impfdatum
- 21.02.2023
- Beginn
- 22.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Tenderness
Symptomtext
Patient received on 2/21/23 a Menquadfi on left deltoid and a Bexsero on the right deltoid. The next day she had mild tenderness on both arms. On 2/26/23-2/28/23. She had more pain on right deltoid. No erythema or warmth at time of visit and no fever. Her left deltoid felt fine at this visit of 2/28/23. She has taken Motrin with no relief. No redness or swelling of right deltoid but is tender to palpation, no bruising.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- 01/27/2023 common cold, ear infection
- Vorgeschichte
- migraines, Depression
- Andere Medikamente
- Fluticasone nasal spray
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 29.11.2022
- Impfdatum
- 21.11.2022
- Beginn
- 22.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain
Pyrexia
Rash
Symptomtext
Patient received vaccines afternoon of 11/21/2022. Patient's mother called back on 11/22/2022 around 3:00 PM reporting that patient was experiencing a fever of 100.7 and a rash to bilateral hands that started at midnight. Mother shared that patient's friends are also sick/running a fever. Discussed with mother that patient had also received a fresh tattoo to left forearm that could be contributing to this as well. Recommended if symptoms worsen to report to urgent care as we would be out of office over the long holiday weekend. Spoke with patient on 11/29/2022 in regards to side effects - patient reports that her rash and fever cleared on the afternoon of 11/24/2022. States that in addition to fever and rash she had also experienced intense body aches, which also subsided afternoon of 11/24/2022. Reports that this was her very first tattoos two days prior to vaccines, a known lamictal allergy, and gabapentin was a new medication 7-14 days prior to vaccinations. Denies any other symptoms that took place nor any other potential contributing factors to said side effects. Patient reports that she is feeling fine and back to normal as of 11/24/2022 and has no other issues to report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Patient received her first tattoo on her left forearm two days prior to her vaccines.
- Vorgeschichte
- N/A
- Andere Medikamente
- Patient currently taking gabapentin 100mg BID, cyclobenzaprine 5mg BID, naproxin 500mg BID, and minocycline 100mg QD. Gabapentin was a new medication for patient, states that she started taking this 7-14 days prior to her vaccine date.
- Allergien
- Patient reports that she has a lamictal allergy and denies any other known allergies.
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 05.10.2022
- Beginn
- 05.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site cellulitis
Symptomtext
Large cellulitis measuring 20 x 20 cm at site of injection ( R Arm)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Mild Asthma
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 13.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal discomfort
Diarrhoea
Fatigue
Malaise
Pain
Pyrexia
Somnolence
Symptomtext
Child has not been feeling well since 09/13. She continues to be achy all over, she is spiking random fevers. She has had diarrhea. After the vaccines almost immediately she spiked a fever and body aches, and GI issues. The fatigue and GI issues have persisted. She slept from 5pm to 11am the next day. This is unusual. Offered an office visit and mother declined, will wait another week to see if things get better. If not, mother will let office know and she will be scheduled ASAP
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- not applicable
- Aktuelle Erkrankungen
- major depressive disorder
- Vorgeschichte
- Sever's disease, migraines, asthma, difficulty concentrating
- Andere Medikamente
- Albuterol, cetirizine, clonidine, sertraline, ibuprofen
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 25.08.2022
- Impfdatum
- 23.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Eye swelling
Urticaria
Vaccination site rash
Symptomtext
The patient broke out in hives and rash around the site of the vaccine yesterday about an hour after administration. Hives continued to spread throughout the body. This morning her right eye was swollen shut on waking but has since gone down. No itchy irritation in the mouth, difficulty swallowing or breathing. Eating and drinking, good energy, sttn. Using benedryl every 6 hours. Prescribed steroids
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- -
- Allergien
- Dairy
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 30.11.2023
- Impfdatum
- 30.11.2023
- Beginn
- 30.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
TDAP Vaccine expired on 10/27/23. PARENT WILL BE NOTIFIED. LOCAL TEAM NOTIFIED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 28.08.2023
- Impfdatum
- 23.08.2023
- Beginn
- 23.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
I gave the pt 2 meningococcal vaccines at one time. I have not been able to reach either parent or patient at this time to see if said patient has had any adverse reactions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Anxiety
- Andere Medikamente
- Cymbalta 40mg qd Vyvanse 30mg qd
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 24.05.2023
- Impfdatum
- 15.05.2023
- Beginn
- 15.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
accidentally administered an extra booster dose with no reported adverse event; Initial information received on 16-May-2023 regarding an unsolicited valid non-serious case received from a physician. This case involves a 12 years old female patient who was accidentally administered an extra booster dose of meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 15-May-2023, the patient accidentally received an extra Booster dose (0.5 mL) of suspect meningococcal A-C-Y-W135 (T conj) vaccine (Strength = Normal), solution for injection (batch number: U7447AC; expiry date: 20-Sep-2024) via intramuscular route in unknown administration site for Immunization with no reported adverse event (Extra dose administered ) (same day latency). It was reported, She wanted to know if it was safe and what will be the next dosing schedule. The latest schedule of administered vaccine did not populate in their system and that is why she accidentally administered an extra booster dose. Prior to giving the extra dose, the last dose was in 4April2022. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event accidentally administered an extra booster dose with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 04.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Medication error
No adverse event
Symptomtext
patient received an extra dose of MENQUADFI with no reported adverse event; Initial information received on 28-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 18 years old female patient where patient received an extra dose of menquadfi with no reported adverse event while receiving vaccine meningococcal a-c-y-w135 (t conj) vaccine [Menquadfi]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hpv vaccine vlp rl1 4v (yeast) (gardasil) and meningococcal vaccine b rfhbpa/fhbpb (trumenba) for Immunisation. On 28-Apr-2023, the patient received 0.5 ml dose of suspect meningococcal a-c-y-w135 (t conj) vaccine Solution for injection (frequency- daily) (batch number- U7447AC and expiration date-20-Sep-2024) via intramuscular route in the right arm (strength: not provided). On 28-Apr-2023 the patient received an extra dose of menquadfi with no reported adverse event (extra dose administered) (latency- same day) following the administration of meningococcal a-c-y-w135 (t conj) vaccine. Action taken- Not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- GARDASIL; TRUMENBA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 01.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Meningococcal was given/administered as a third dose. Vaccine was administered, 04/28/2023, extra as third dose when she had already received her second dose and was fully vaccinated for her age.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- No testing required and or needed. Patient admitted to no reaction and or symptoms.
- Aktuelle Erkrankungen
- No.
- Vorgeschichte
- None.
- Andere Medikamente
- None.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,6
- Geschlecht
- U
- Eingang
- 18.03.2023
- Impfdatum
- 09.03.2023
- Beginn
- 09.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
menquadfi vaccine was given to a patient under the age of 2 with no reported AE; Initial information received on 10-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 7 months old of an unknown gender and reporter reported Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] vaccine was given to a patient under the age of 2 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal Vaccine Conj 13v (Crm197) (Prevnar 13) For Immunisation; Hib Vaccine Conj (Tet Tox) (Acthib) for Immunisation; and Diphtheria Vaccine Toxoid, Hepatitis B Vaccine Rhbsag (Yeast), Pertussis Vaccine Acellular 3-Component, Polio Vaccine Inact 3v (Vero), Tetanus Vaccine Toxoid (Pediarix) for Immunisation. On 09-Mar-2023, the patient received 0.25 ml of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine Solution for injection (lot number: U7447AC, Expiry date: 20-Sep-2024, Strength: Standard, Frequency: Once) via intramuscular route in the right thigh for Immunization. On 09-Mar-2023, the patient was given Meningococcal A-C-Y-W135 (T Conj) Vaccine was given to a patient under the age of 2 with no reported adverse event (product administered to patient of inappropriate age) (latency: same day). It was reported, MENQUADFI vaccine was given to a patient under the age of 2. They are wondering what to look for as far as any adverse reactions. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event (menquadfi vaccine was given to a patient under the age of 2 with no reported AE). At time of reporting, the outcome was Unknown for the event menquadfi vaccine was given to a patient under the age of 2 with no reported ae. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PREVNAR 13; ACTHIB; PEDIARIX
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- F
- Eingang
- 15.02.2023
- Impfdatum
- 02.08.2022
- Beginn
- 06.02.2023
- Tage bis Beginn
- 188,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental exposure to product
Extra dose administered
No adverse event
Symptomtext
inadvertently administered an extra dose with no reported adverse event; Initial information received on 10-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 18 years old female patient who reported inadvertently administered an extra dose of vaccine meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Aug-2022, the patient received a dose of suspect meningococcal A-C-Y-W135 (T CONJ) solution for injection vaccine 0.5 ml total lot U7447AC strength not reported via unknown route in unknown administration site. On 06-Feb-2023 she also received a dose of the same vaccine 0.5 ml lot U7447AC via unknown route in unknown administration site for prophylactic vaccination. On 06-FEB-2023 the patient developed a non-serious inadvertently administered an extra dose with no reported adverse event (accidental exposure to product). Action taken was not applicable. At time of reporting, the outcome was Unknown for the event inadvertently administered an extra dose with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental exposure to product
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 14.10.2022
- Beginn
- 03.01.2023
- Tage bis Beginn
- 81,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Adverse Event: patient came in on 01/03/2023 for a routine clinic visit and it was called to the medical assistant that patient was due for a booster dose vaccine which was already given during 10/14/2022 office visit. Which was documented into patients chart erroneously.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 15.12.2022
- Impfdatum
- 19.09.2022
- Beginn
- 19.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
woman received MENQUADFI while pregnant with no adverse event; Initial information received on 12-Dec-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves a 16-year-old female patient who was exposed to vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] in context of woman received menquadfi while pregnant with no adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The patient was exposed to MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE at 26 weeks of pregnancy, during third pregnancy trimester for MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. The date of last menstrual period was reported as 22-Mar-2022. The estimated due date is 10-Jan-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had previous pregnancies. On 19-Sep-2022, the patient received suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (formulation: unknown) Strength: standard at dose of 0.5ml total (lot number: U7447AC and expiry date: 20-Sep-2024) via intramuscular route in the left deltoid for Immunization and woman received menquadfi while pregnant with no adverse event (exposure during pregnancy) (latency: same day). It was reported, she would like to know if she should be put on the registry? The patient was transferred to them for prenatal care. She received the vaccine at another clinic location. Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable. At time of reporting, the outcome was Unknown. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- F
- Eingang
- 23.11.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
patient received MENQUADFI after it experienced a temperature excursion, with no reported adverse event; patient received MENQUADFI after it experienced a temperature excursion, with no reported adverse event; Initial information received from on 16-Nov-2022 regarding an unsolicited valid non-serious case from a other health professional. This case involves a 16 years old female patient who received Meningococcal A-C-Y-W135 (T CONJ) vaccine [MENQUADFI] after it experienced a temperature excursion, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Hpv Vaccine ; and Influenza Vaccine. On 21-Oct-2022, the patient received a dose of suspect Meningococcal A-C-Y-W135 (T CONJ) vaccine solution for injection at dose 0.5 ml(lot U7447AC and expiry date: 20-SEP-2024) (with unknown strength, frequency) via intramuscular route in Left Deltoid for immunization, after it experienced a temperature excursion, with no reported adverse event (product storage error),(Poor quality vaccine administered) (Latency: same day) following the administration of Meningococcal A-C-Y-W135 (T CONJ) vaccine. Action taken was not applicable. The outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 19.11.2022
- Impfdatum
- 14.11.2022
- Beginn
- 14.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incomplete course of vaccination
Symptomtext
Pt was given bivalent Pfizer Booster before completing primary series w/monovalent Pfizer (only had 1 monovalent Pfizer from 1/15/22)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incomplete course of vaccination
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Viral URI / Asthma Flare
- Vorgeschichte
- Asthma
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 04.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Cellulitis
Erythema
Feeling hot
Fluid retention
Soft tissue swelling
Swelling
Ultrasound scan abnormal
Symptomtext
Swelling, redness, heat Cellulitis - worsening / spreading over 4 days despite abx. (Keflex) Seen in ED changed to Clindamycin
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- US - soft tissue swelling, fluid
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- asthma hypothyroidism
- Andere Medikamente
- Flonase, ProAir, Zyrtec
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 05.10.2022
- Impfdatum
- 22.09.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 4,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
MENACTRA and MENQUADFI being administered within a week of each other on accident with no adverse event; Initial information received on 30-Sep-2022 regarding an unsolicited valid non-serious case via other health professional. This case involves a 12 years old female patient who had MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] being administered within a week of each other on accident with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 22-Sep-2022, the patient received suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site for immunisation. On 26-Sep-2022, the patient received, 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (lot U7447AC, expiry date: 20-Sep-2024) via intramuscular route in the right deltoid for immunisation. On 26-Sep-2022, menactra and menquadfi were being administered within a week of each other on accident with no adverse event (extra dose administered) same day latency following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE and 4 days following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 23.09.2022
- Impfdatum
- 22.09.2022
- Beginn
- 22.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product preparation issue
Symptomtext
Covid vaccine found to have not been diluted prior to administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- None Known
- Vorgeschichte
- ADHD
- Andere Medikamente
- Children's Chewable Multivitamin
- Allergien
- None Known
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 14.09.2022
- Impfdatum
- 18.08.2022
- Beginn
- 18.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Wrong product administered
Symptomtext
Patient had series of HPV9 vaccine July 2017 and June 2019 Patient was only to get Meningococcal vaccine, was accidently given HPV9
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Wheezing, Vitamin D deficiency
- Andere Medikamente
- Vitamin D, ProAir
- Allergien
- -
- Vorherige Impfungen
- -